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Abstract
V-set and transmembrane domain-containing protein 5 (Vstm5), a newly characterized
small membrane glycoprotein, can induce membrane protrusions in various cells. Vstm5
can modulate both the position and complexity of central neurons by altering their mem-
brane morphology and dynamics. In this study, we investigated the significance of glycosyl-
ation in the expression and function of Vstm5. Four N-linked glycosylation sites (Asn43,
Asn87, Asn101, and Asn108) are predicted to be located in the extracellular N-terminus of
mouse Vstm5. Although all four sites were glycosylated, their functional roles may not be
identical. N-glycosylation at multiple sites affects differentially the function of Vstm5. Glyco-
sylation at individual sites not only played essential roles in surface expression of Vstm5 but
also in the formation of neuronal dendritic filopodia. These results indicate that N-linked gly-
cosylation at multiple sites plays important roles by differentially influencing the expression,
targeting, and biological activity of Vstm5.
Introduction
V-set and transmembrane domain-containing protein 5 (Vstm5) is a small putative cell-adhe-
sion molecule belonging to the immunoglobulin superfamily abundantly expressed in mouse
brain. Vstm5 is highly expressed at postnatal day 1 in mouse brain, when synaptogenesis
actively occurs [1]. This temporal expression pattern suggests that Vstm5 modulates neuronal
connectivity and plasticity. In fact, Vstm5 regulates neuronal morphology by redistributing F-
actin and promotes synapse formation [2]. In addition, Vstm5 promotes neurite formation in
the leading processes of migrating neurons to facilitate dendrite formation and integration of
neurons into the appropriate laminae of the developing mouse cortex [2].
Our previous study showed that Vstm5 can be glycosylated at multiple sites and suggested
that four potential N-linked glycosylation sites are located in its extracellular domain [2].
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Cellular N-glycosylation is highly regulated in response to developmental, physiological, and
environmental cues, in part through changes in the expression of glycosyltransferases that
function in the endoplasmic reticulum (ER) and the Golgi [3]. In many systems, glycosylation
plays a role in surface expression as well as protein stability [4, 5]. For example, several mem-
brane proteins, including ion channels, transporters, and receptors that contain N-linked gly-
can in their mature forms, are involved in membrane targeting [6–11]. Recent reports indicate
that impaired N-glycosylation can cause various disorders of the central nervous system [12].
For example, abnormal N-glycosylation of neurotransmitter-related proteins and amyloid pre-
cursor protein (APP) has been reported in patients with schizophrenia and Alzheimer disease
(AD) [13–16].
In this study, we characterized the effect of N-linked glycosylation of Vstm5 on its expres-
sion and function. We showed that all four N-linked glycosylation sites predicted by bioinfor-
matic analysis are in fact glycosylated in the cell. However, glycosylation at each site had
differential effects on the surface expression of Vstm5 and filopodia induction. Thus, N-linked
glycosylation at multiple sites appears to be critical for the expression, targeting, and function
of Vstm5.
Materials and methods
DNA constructs and molecular cloning
The full-length complementary DNA (cDNA) of the Vstm5 protein was purchased from Clo-
neRanger (Invitrogen). Vstm5 cDNA was amplified using PCR and then subcloned in-frame
into pEGFP-N3 (Clonetech). The C-terminus of Vstm5 was also tagged with a monoclonal
antibody epitope (Vstm5::1D4) by replacing EGFP in pEGFP-N3 with a C-terminal rhodopsin
1D4 tag [17]. To construct the C-terminal point mutants, Vstm5-N43A, -N87A, -N101A,
-N108A, -N43,87A, -N101,108A, -N87,101,108A, and -N43,87,101,108A were subcloned into
pEGFP-N3 tagged with the green fluorescent protein (GFP) or 1D4 epitope.
Antibodies
The following antibodies commercially available were used: a rabbit polyclonal antibody
directed against recombinant full length GFP (1/1000; ab290, Abcam); a mouse monoclonal
[1D4] directed against cow rhodopsin (1/1000; ab5417, Abcam); and a rabbit polyclonal
directed against microtubule-associated protein 2 (1/500; sc-20172, Santa Cruz Biotechnol-
ogy). The secondary antibody used for immunocytochemistry was an Alexa Fluor-conjugated
antibody (Alexa 488, Alexa 594, and Alexa 633; 1/1000; Invitrogen). For western blot analysis,
a horseradish peroxidase-conjugated secondary antibody (1/10000; Jackson ImmunoResearch
Laboratories) was used. Texas Red-X Phalloidin was used to assess filamentous actin (1/1000;
T7471, Molecular Probes).
Cell culture and transfection
Both human embryonic kidney 293 cells (HEK 293) and African green monkey kidney fibro-
blast-like cells (COS-7) were cultured at 37˚C in Dulbecco’s Modified Eagle’s Medium
(Hyclone) supplemented with 10% fetal bovine serum (Hyclone) in a humidified atmosphere
containing 5% CO2. Cells were transfected using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Wild-type ICR mice with 18 days of pregnancy were pur-
chased from Damul Science (Damul Science, Daejeon, Korea). All experiments used protocols
approved by the Animal Care and Ethics Committees of the Gwangju Institute of Science and
Technology (permit number: GIST-2014-52) in accordance with the National Institutes of
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Health Guide for the Care and Use of Laboratory Animals. Mouse hippocampal neuronal cul-
tures were prepared as described previously [18]. Briefly, hippocampi were dissected from E18
mice and dissociated with papain (Worthington Biochemical Corp). The cells were plated on
poly-D-lysine-coated cover glasses at a density of 5 × 105 cells per 60-mm plastic dish. They
were maintained in Neurobasal medium (Gibco) supplemented with B-27 (Invitrogen) and 2
mM L-GlutaMAX (Invitrogen). Neurons were transfected at day in vitro (DIV) 1 or 2 using a
modified calcium-phosphate precipitation method [19].
Deglycosylation of Vstm5 using tunicamycin and enzymes
Cells were transiently transfected with Vstm5 constructs. Six hours after transfection, tunica-
mycin was added to the medium at various concentrations (0, 0.5, 1.0, and 5.0 μg/ml). Cells
were harvested 4 h after the addition of tunicamycin using RIPA buffer (20 mM HEPES, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% sodium deoxycholic acid, 1% Triton X-100, 2 mM
Na3VO4, 1% NP-40, 2 mM NaF, and 1× protease inhibitor cocktail [Complete; Roche Diag-
nostics]). In order to remove glycosylation of Vstm5, the cells were treated with endoglycosi-
dase H (endo H) or peptide-N-glycosidase F (PNGase F) (New England Biolabs) at 1U/μg
protein for 16 h at 37˚C, according to the manufacturer’s instructions. The effects of chemical
and enzymatic treatments on Vstm5 glycosylation were analyzed using SDS-PAGE, followed
by immunoblotting. Bands corresponding to surface biotinylated WT and mutant Vstm5 were
quantified using ImageJ software and then normalized to the amount of total lysate.
Biotinylation and western blot analysis
Transfected COS-7 cells were rinsed twice in phosphate-buffered saline (PBS2+) supplemented
with 0.1 mM CaCl2 and 1 mM MgCl2 and incubated with Sulfo-NHS-LC-biotin (Thermo Sci-
entific) at a concentration of 0.5 mg/ml for 1 h on ice. The cells were rinsed three times in
PBS2+ and lysed in 1 ml of lysis buffer (25 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% sodium
deoxycholic acid, 1% Triton X-100, 0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, and 1×
protease inhibitor cocktail [Complete; Roche Diagnostics]) for 30 min on ice. Aliquots of the
lysates (10% of the total cell lysate) were subjected to western blot analysis with an anti-1D4
antibody. Biotinylated proteins were precipitated from the remaining 90% of the lysate with
streptavidin-agarose beads (Thermo Scientific). Precipitates were washed three times with PBS
and eluted into sample buffer. Samples were resolved by SDS/PAGE and immunoblotted with
an anti-1D4 antibody at 4˚C overnight. After extensive washing in 1 × TBST, the membrane
was incubated with a horseradish peroxidase-conjugated secondary antibody (Jackson Immu-
noResearch Laboratories). Proteins were visualized with ECL reagent (GE Healthcare Life
Sciences).
Immunofluorescence and confocal microscopy
COS-7 cells and hippocampal neurons were washed three times with PBS and then with 4%
paraformaldehyde/sucrose prepared in PBS for 15 min at room temperature. After washing,
the cells were permeabilized with 0.25% Triton X-100 prepared in PBS for 5 min at room tem-
perature and blocked with 5% bovine serum albumin prepared in PBS for 30 min. The cells
were incubated with a primary antibody for 1 h and subsequently with a fluorescence-conju-
gated secondary antibody for 45 min. Fluorescence images were acquired using a Fluoview FV
1000 confocal laser-scanning microscope equipped with 100× oil-immersion objectives and
capable of an additional ×4 zoom.
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Image analysis and quantification
Analysis and quantification of data were performed using ImageJ. In COS-7 cells, the total
number of filopodia was counted, and the total number was divided by the length of cell cir-
cumference to generate the number of filopodia per μm. In neurons, we imaged at 7 DIV
when dendritic spine induction has not yet occurred, and filopodia are the predominant den-
dritic protrusion. We thus defined dendritic filopodia as any protrusion under 10 μm in den-
dritic length. Statistical comparisons were performed by ANOVA followed by a Dunnett’s
posthoc test making comparison against a single control group. P values of less than 0.05 were
considered significant. Data are presented as mean ± standard error of the mean (SEM).
Results
Vstm5 is a glycoprotein with multiple N-linked glycosylation sites
Vstm5 is a highly conserved protein in different species, especially in mammals [2]. While
three out of four (Asn43, Asn87, and Asn101) predicted N-linked glycosylation sites are con-
served in the extracellular domain, one site (Asn108) is found specifically in mouse (Fig 1A).
Fig 1. Locations of putative N-glycosylation sites and confirmation of N-glycosylation of Vstm5. (A) The extracellular region sequences of
Vstm5 from Mus musculus (NP_081231), Rattus norvegicus (NP_001138342), Equus caballus (XP_001491444.3), Homo sapiens (NP_001138343),
Sus scrofa (XP_003129835), Bos taurus (NP_001193893), Canis lupus (XP_005633416), and Xenopus tropicalis (XP_004912166) were multi-
aligned using Clustal X. The conserved N-linked glycosylation sites and transmembrane domain are boxed in light gray and dark gray, respectively.
(B) COS-7 cells transfected with Vstm5::1D4 were treated with tunicamycin at the indicated concentration for 6 h after transfection. (C, D) Total
Vstm5::1D4-expressing (C) or Vstm5::GFP-expressing (D) cell lysates were treated with 1U endoH and then 1U PNGase F. Samples were resolved
by SDS-PAGE, followed by western blotting with an anti-1D4 or anti-GFP antibody. Gapdh served as loading control.
https://doi.org/10.1371/journal.pone.0181257.g001
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This Asn residue is replaced by Ser residues in other species, except Xenopus. As we previously
reported [2], Vstm5 was detected as multiple protein bands at apparent molecular weights of
30–45 kDa. Treatment with tunicamycin, an antibiotic that blocks the synthesis of N-linked
oligosaccharide chains on glycoproteins, shifted the multiple protein bands to a single band of
approximately 20 kDa in a dose-dependent manner (Fig 1B). To determine the glycan matura-
tion of Vstm5 in COS-7 cells at steady state, cell lysates expressing Vstm5::1D4 or Vstm5::GFP
were digested with endo H or PNGase F to remove the entire glycan chain (Fig 1C and 1D).
Digestion with endo H generated protein bands of around 20–30 kDa for Vstm5::1D4 (Fig 1C)
or 55kDa for Vstm5::GFP (Fig 1D), respectively, termed endo H-sensitive bands. Because
endo H cleaves immature proteins, the endo H-sensitive bands represent Vstm5 that has not
been processed beyond the endoplasmic reticulum (ER). Digestion with PNGase F also gener-
ated a protein band at 21 kDa (Fig 1C) or 55kDa (Fig 1D), representing fully deglycosylated
Vstm5. These results indicate that Vstm5 is glycosylated mostly, if not absolutely, by N-linked
forms and that the majority of Vstm5 is expressed as an endo H-sensitive mature form in cells.
N-glycosylation is critical for surface expression of Vstm5
To confirm the glycosylation of the four candidate Asn residues, we generated 1D4-tagged
Vstm5 mutants. The four Asn residues were replaced by Ala individually or in combination,
and the mutants were expressed in COS-7 cells (Fig 2). All four single mutations changed the
migration patterns of the protein bands and shifted them to positions lower than that of wild-
type (WT) Vstm5 (Fig 2B and 2C), indicating that all four predicted sites (Fig 2A) were indi-
vidually glycosylated in the cell. Most single and double mutants were detected at around 20–
30 kDa and also at multiple bands around 37 kDa (fully matured form). These results indicate
that the glycosylation of multiple sites is critical for proper trafficking of Vstm5 from the ER to
the Golgi apparatus or from the Golgi apparatus to the plasma membrane. By contrast, the tri-
ple and quadruple mutants were detected only at around 21 kDa, indicating that they are
trapped in the ER or retained in other compartments after exiting the ER.
Vstm5 was glycosylated at multiple sites; therefore, their functional importance was further
investigated. We wondered whether the inhibition of glycosylation interferes with the target-
ing of Vstm5 to the cell membrane and/or the formation of membrane protrusions. To
determine its subcellular distribution, the expression pattern of Vstm5 was compared with
that of an ER marker, protein disulfide isomerase (PDI). WT Vstm5 was mainly expressed at
the membrane edges of COS-7 cells and induced membrane protrusions (Fig 2D). In the
presence of tunicamycin, however, Vstm5 was trapped at the perinuclear region and co-local-
ized with PDI. These results strongly suggested that N-linked glycosylation of Vstm5 was nec-
essary for its proper targeting to the plasma membrane. Consistently, the quadruple mutant
(N43,87,101,108A) had a similar intracellular localization pattern and failed to induce mem-
brane protrusions (Fig 2E). Thus, N-linked glycosylation of the extracellular domain may be
critical for the surface expression of Vstm5.
N-linked glycosylation has differential effects on membrane expression
of Vstm5
N-linked protein glycosylation is crucial for the trafficking of several membrane proteins
toward the plasma membrane [4, 20, 21]. To appreciate the effects of N-linked glycosylation of
individual sites on surface expression, we performed a surface biotinylation assay using differ-
ent glycosylation mutants (Fig 3A). In order to measure the intensity of total protein bands
accurately, PNGase F was added to each lysate to remove glycosylation before performing the
pull-down procedure. The western bands shown in Fig 3B were quantified for comparison.
Effects of N-linked glycosylation on expression and function of Vstm5
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Fig 2. N-linked glycosylation of Vstm5 at multiple sites. (A) A schematic illustration of Vstm5 mutants harboring mutations in the
four putative N-glycosylation sites. Blue lines with filled circles indicate glycosylation sites (Asn43, Asn87, Asn101, and Asn108). (B) Each
mutant was transfected into COS-7 cells. (C) Lysates of COS-7 cells expressing WT and mutant Vstm5 were treated with tunicamicin or
PNGase F, followed by SDS-PAGE and western blotting with an anti-1D4 antibody. Tu, tunicamycin-treated. Un, untreated control. P,
PNGase F-treated. Gapdh served as loading control. (D) Vstm5-transfected COS-7 cells were treated with DMSO (control) or 1 μg/ml
Effects of N-linked glycosylation on expression and function of Vstm5
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Among the single point mutants, the plasma membrane expression of N43A and N101A was
lower than that of WT Vstm5. Intriguingly, the surface expression of N87A and N108A was
increased (1.4-fold and 1.3-fold, respectively) compared with that of WT Vstm5. Among the
multiple point mutants, surface expression was significantly decreased for all mutants except
for the N101,108A double mutant. The level of N101,108A in the plasma membrane was not
significantly different with that of WT Vstm5 (Fig 3C). These results demonstrate that N-
linked glycosylation at Asn43 sites was critical for surface expression of Vstm5. However, gly-
cosylation at Asn87and Asn108 was not necessary for efficient recruitment of Vstm5 to the
plasma membrane.
N-linked glycosylation modulates filopodia induction by Vstm5
Since the conventional filopodial structures are tightly linked to parallel bundles of actin fila-
ments [22, 23], F-actin can be visualized by labeling the cells with phalloidin in filopodial
structure. We reported previously that Vstm5 induces filopdoia and colocalizes with F-actin in
tunicamycin for 24 h and immunostained with an anti-1D4 antibody (green) and an anti-PDI antibody (red). (E) COS-7 cells transiently
transfected with the Vstm5 (N43,87,101,108A) mutant were immunostained with an anti-1D4 antibody (green) and an anti-PDI antibody
(red). Scale bar, magnification: 30 μm.
https://doi.org/10.1371/journal.pone.0181257.g002
Fig 3. Plasma membrane expression of WT and mutant Vstm5. (A, B) WT Vstm5 and its glycosylation mutants expressed in cells were
biotinylated and subsequently precipitated using Neutravidin-agarose. The Vstm5-containing lysates were treated without (A) or with PNGase F
(B). (C) Surface levels of biotinylated WT and mutant Vstm5 were normalized to that of total protein in (B). The western blot is representative of
three individual experiments. Data represent means ± SEM (*P<0.05, **P<0.01, ***P<0.001, n.s., no statistical significance, significantly different
from WT Vstm5 by an ANOVA and Tukey’s HSD post hoc test).
https://doi.org/10.1371/journal.pone.0181257.g003
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neuronal and non-neuronal cells [2]. To verify the effects of N-glycosylation on filopodia
induction, we analyzed the number and length of filopodia in COS-7 cells. WT and mutant
Vstm5 were individually tagged with 1D4 and transfected into COS-7 cells, and then cells were
stained with an anti-1D4 antibody (green) and phalloidin (red) (Fig 4A). The density of filopo-
dia was higher in cells expressing Vstm5::1D4 (Fig 4B) than in GFP-transfected control cells
(Fig 4A and 4K). In cells expressing the N43A, N87A, and N101A single mutants, the density
of filopodia was significantly reduced compared with that of WT Vstm5 (Fig 4B, 4C, 4D, 4E
and 4K). However, the N108A mutant induced filopodia as potently as WT Vstm5, suggesting
the functional insignificance of Asn108 in filopodia induction (Fig 4F and 4K). Effects of multi-
ple mutations on the ability of Vstm5 to induce membrane protrusion in COS-7 cells were
also complex and somewhat additional. The number of membrane protrusions induced by a
triple mutant, N87,101,108A, was greatly reduced compared with that of WT Vstm5 or with
the individual single mutants. The quadruple mutant N43,87,101,108A failed to target the cell
surface and did not colocalize with F-actin (Fig 4J). As expected, the quadruple mutant could
not induces additional membrane protrusion compared with GFP control (Fig 4K). Despite
the marked effects of WT and mutant Vstm5 on the filopodial density, the length of filopodia
was not significantly affected (Fig 4L). These results indicate that N-glycosylation of Vstm5 is
closely related not only to its surface expression, but also to filopodia induction.
N-linked glycosylation modulates induction of neuronal dendrites by
Vstm5
In early synaptogenesis, dendritic filopodia play critical roles in actively initiating contacts
with nearby axonal shafts, and pre- and postsynaptic molecules are rearranged and thereafter
evolve into dendritic spines [24]. In our previous study [2], we found that Vstm5 induces
mainly filopodia on the dendritic regions of a neuron. To examine the functional effects of N-
linked glycosylation on Vstm5-induced formation of dendritic filopodia, we transfected WT
Vstm5 and N-linked glycosylation mutants of Vstm5 into mouse hippocampal neurons (DIV
1). The neurons were stained for F-actin with phalloidin and for MAP2, a dendritic marker,
with anti-MAP2 antibody. As previously reported [2], the number of dendritic filopodia was
higher in WT Vstm5-expressing neurons than in GFP-expressing control neurons (Fig 5A, 5B
and 5K). However, the single mutations affected differentially Vstm5 for its ability to induce
dendritic filopodia. While the single N-glycosylation mutants N87A and N101A exhibited sig-
nificantly fewer dendritic filopodia than those transfected with WT Vstm5 (Fig 5B, 5D, 5E and
5K), both N43A and N108A showed no significant differences in the number of dendritic filo-
podia compared with WT Vstm5 (Fig 5B, 5C, 5F and 5K). The reducing effects of dendritic
filopodia was most prominent for N101A (Fig 5E and 5K), suggesting the importance of N-gly-
cosylation on this position. We then tested the multiple mutants for their ability to induce den-
dritic filopodia, since these mutant Vstm5 (N43,87A, N101,108A, and N87,101,108A) were
targeted to cell surface and able to induce some membrane protrusions in COS-7 cells (Fig 4G,
4H and 4I). Surprisingly, however, the multiple mutants only except N43,87A was not able to
increase the number of filopodia significantly in the dendritic regions of transfected neurons
compared with the GFP-transfected control neurons (Fig 5G, 5H and 5I). As expected in
COS-7 cells, the quadruple mutant could not induces dendritic filopodia same as GFP control
(Fig 5K). All of the Asn101 loss mutants are decreased in dendritic filopodia formation. These
results indicate that N-glycosylation at Asn101 is the most important modification for dendritic
filopodia formation.
The length of dendritic filopodia in neuron transfected with WT Vstm5 and any of the
mutants were not significantly different, except N108A in which the dendritic filopodial length
Effects of N-linked glycosylation on expression and function of Vstm5
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Fig 4. Effects of N-glycosylation on Vstm5-induced filopodia formation. (A–J) Immunocytochemistry of WT
Vstm5::1D4 and its glycosylation mutants. Transfected COS-7 cells were stained with an anti-1D4 antibody (green), and
phalloidin (red). Higher magnification views of the regions enclosed by the rectangle are shown below each image. Scale
bar, low magnification: 30 μm; high magnification: 10 μm. (K, L) Histograms of the number (K) and length (L) of filopodia
were quantified and divided by the length of cell circumference. Analysis was performed using Image J (public domain,
Effects of N-linked glycosylation on expression and function of Vstm5
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was significantly shorter than rest of them (Fig 5L). These results are partially consistent with
the aforementioned findings in COS-7 cell lines and further indicate the functional signifi-
cance of glycosylation of the extracellular domain of Vstm5 in the formation of neuronal den-
dritic filopodia.
Discussion
Among protein post-translational modifications, the most well-studied and most complex
modification is the N-linked glycosylation of the Asn residue in the consensus motif Asn-
X-Ser/Thr [25]. N-glycosylation, which mainly occurs in secreted, cytosolic or membrane pro-
teins, plays important roles in correct protein folding, assembly and stability [3], as well as in
cell adhesion and diverse signaling pathways [26, 27]. The emergence of a new N-glycosylation
site during evolution can alter protein function either positively or negatively [28]. In the pres-
ent study, we showed that Vstm5, a newly characterized membrane protein, undergoes N-
linked glycosylation at multiple sites. This glycosylation is critical not only for the expression
of Vstm5 at the plasma membrane but also for the induction of membrane protrusions. Treat-
ment with tunicamycin, which inhibits the action of glycosyltransferases in the ER, and muta-
tion of the four predicted N-linked glycosylation sites prevented Vstm5 from reaching the cell
surface and caused it to become trapped in the ER (Fig 2D and 2E). These results suggested
that glycosylation is a key element for the proper trafficking and surface expression of Vstm5.
In general, the ER has been recognized as a checkpoint for protein quality control [29]. The
localization of non-glycosylated forms of Vstm5 in the ER suggests that adequate glycosylation
is required for Vstm5 to transit to the Golgi complex for further processing. The decreased sta-
bility of other membrane proteins has been attributed to a lack of glycosylation [5, 30], also
raising the possibility that immature glycosylation may direct Vstm5 for degradation.
Three Asn residues in the N-terminal extracellular domain of Vstm5 (Asn43, Asn87, and
Asn101) are well conserved in vertebrates, implying that N-linked glycosylation is a common
post-translational modification of vertebral Vstm5. We found that N-glycosylation can modu-
late the surface expression of Vstm5 and the formation of filopodia-like structures. It was
reported that some proteins, such as the ß4 subunit of sodium channel and the acid-sensing
ion channel-1a (ASIC1a), can induce the filopodia-like structures in a glycosylation-dependent
manner [9, 10]. Especially, N-glycosylation at Asn393 and Asn366 in ASIC1a has differential
effects on ASIC1a biogenesis. The N366Q mutant of ASIC1a, which shows increased surface
expression, glycosylation and dendritic targeting, potentiated acidosis-induced spine loss.
Conversely, the N393Q mutant of ASIC1a, which showed a decrease in dendritic targeting and
inhibition of ASIC1a current dominant-negatively, had the opposite effect [9].
Mutation of four N-linked glycosylation sites in Vstm5 had significant functional effects on
its expression and filopodia induction. Although total protein expression was not significantly
affected by glycosylation mutations, targeting to the cell surface was differentially affected by
these mutations (Fig 3). While N43A and N101A has lower surface expression (Fig 3), only the
N101A mutant was important for filopodia formation (Fig 5). These results indicate that the
Asn101 residue is not only critical for the recruitment of Vstm5 to the plasma membrane but is
also essential for the formation of dendritic filopodia in neurons. The cell surface expression of
Wayne Rasband, USA). Data represent means ± SEM (GFP, n = 25; Vstm5, n = 64; Vstm5 [N43A], n = 61; Vstm5 [N87A],
n = 57; Vstm5 [N101A], n = 66; Vstm5 [N108A], n = 67; Vstm5 [N43,87A], n = 68; Vstm5 [N101,108A], n = 38; Vstm5
[N87,101,108A], n = 30; Vstm5 [N43,87,101,108A], n = 28). *, indicates significant difference compared with WT Vstm5,
*P<0.05, **P<0.01, ***P<0.001. #, indicates significantly different from GFP versus Vstm5 or mutants, #P<0.05, ##P<0.01,
###P<0.001. n.s., no statistical significance.
https://doi.org/10.1371/journal.pone.0181257.g004
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Fig 5. Effects of N-linked glycosylation on Vstm5-induced neuronal filopodia. (A–J) Mouse hippocampal neurons (DIV 7) were
transfected with control GFP, WT Vstm5::1D4, or N-linked glycosylation mutants. Immunocytochemistry was performed using an anti-1D4
antibody (green), phalloidin (red), and an anti-MAP2 antibody (blue). Scale bar: high magnification, 5 μm. (K, L) The number (K) and
length (L) of dendritic filopodia. Data represent means ± SEM (GFP, n = 46; Vstm5, n = 71; Vstm5 [N43A], n = 58; Vstm5 [N87A], n = 49;
Vstm5 [N101A], n = 46; Vstm5 [N108A], n = 66; Vstm5 [N43,87A], n = 50; Vstm5 [N101,108A], n = 33; Vstm5 [N87,101,108A], n = 33;
Vstm5 [N43,87,101,108A], n = 14). *P<0.05, ***P<0.001 compared to the WT Vstm5; #P<0.05, ##P<0.01, ###P<0.001 compared to the
GFP; n.s., no significance.
https://doi.org/10.1371/journal.pone.0181257.g005
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the N87A and N108A was even higher than that of WT Vstm5 (Fig 3). Despite its ample
expression at the cell surface, this mutant failed to induce more membrane filopodia than WT
Vstm5 (Figs 4K and 5K), indicating that surface expression per se is not sufficient for the for-
mation of membrane protrusions. Therefore, four different N-glycosylation sites in Vstm5
have differential effects on the formation of filopodia as well as the surface expression.
It is worth noting that the N108A mutant successfully expressed on the cell surface and
induces significantly shorter filopodial extensions than WT Vstm5 and GFP control (Fig 5L).
This result suggests that glycosylation of the Asn108 residue may be important for dendritic
spine maturation of neurons. The Asn108 residue is an N-linked glycosylation site found
specifically in mouse Vstm5 compared to other mammals (Fig 1A). Thus, glycosylation at
Vstm5-Asn108 may play other functional roles specific to mouse. During evolution, the gain of
new N-glycosylation sites is known to affect the protein structural and molecular function
[28]. The new glycosylation sites can be preserved during evolution, when the novel modifica-
tions confer beneficial properties.
The morphology of neurons is important for the functional neural circuit and is related to
brain pathophysiology. As previously reported, Vstm5 increased dendritic complexity and
synapse formation in vivo as well as in vitro and controlled neuronal migration in the brain
[2]. N-linked glycosylation can also affect neuronal morphology and synapse formation during
neuronal development [31]. Many studies have reported that abnormal N-glycosylation of
membrane proteins are associated with various brain diseases including schizophrenia and
depression [13–15, 32]. Thus, it will be of interest to determine whether the Vstm5-Asn101 (the
key residue of Vstm5, inducing filopdoia) and Vstm5-Asn108 (the evolutionary adapted resi-
due, inducing short dendritic filopodia) have any functional consequences for the develop-
ment and maturation of the neuronal circuit and brain function in general. It is also worth
noting that Vstm5 was recently identified as one of the target genes responsible for the differ-
ential response to the treatment of major depressive disorder [33], implying possible roles of
Vstm5 in psychiatric diseases.
Taken together, our results strongly suggest that N-glycosylation at multiple sites not only
plays essential roles in surface expression of Vstm5 but also the formation of neuronal den-
dritic filopodia. Moreover, glycosylation at individual sites may differentially affect the func-
tion of Vstm5 by influencing the expression and maturation of this small membrane protein
with a simple structure.
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